Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Immunology|June 1, 1994
Augmentation of antigen-specific lymphoproliferative responses in vitro by biological response modifiersT D de Gruijl, J J Moore, E de Vries, et al.
Fertility and Sterility|February 6, 1999
Corticosteroids do not influence ovarian responsiveness to gonadotropins in patients with premature ovarian failure: a randomized, placebo-controlled trialY M van Kasteren, D D Braat, D J Hemrika, et al.
American Journal of Obstetrics and Gynecology|October 1, 1995
Underlying disorders associated with severe early-onset preeclampsiaG A Dekker, J I de Vries, P M Doelitzsch, et al.
The Journal of Pediatrics|April 1, 1996
High frequency of celiac disease in Down syndromeE K George, M L Mearin, J Bouquet, et al.
Surgery|July 27, 1999
A prospective randomized study of the systemic immune response after laparoscopic and conventional Nissen fundoplicationC Sietses, M J Wiezer, Q A Eijsbouts, et al.
Scandinavian Journal of Gastroenterology|November 1, 1995
Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumor necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controlsG Bouma, M Oudkerk Pool, J G Scharenberg, et al.
Contact Dermatitis|August 1, 1990
Low allergenicity of clonidine impedes studies of sensitization mechanisms in guinea pig modelsR J Scheper, B M von Blomberg, J de Groot, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1994
Persistent augmentation of natural-killer- and T-cell-mediated cytotoxicity in peripheral blood mononuclear cells pulsed in vitro with high-dose recombinant interleukin-2 prior to culturing with a low maintenance doseP A Palmer, J G Scharenberg, B M von Blomberg, et al.
The Laryngoscope|June 1, 1987
Effect of P15E related retroviral material isolated from head and neck carcinomas on delayed type hypersensitivity skin reactions in miceI B Tan, H A Drexhage, R J Scheper, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The development of anti-interleukin-2 (IL-2) antibodies in cancer patients treated with recombinant IL-2J G Scharenberg, A G Stam, B M von Blomberg, et al.
Pageof 7